Epitalon has no approved label and no Western-validated human dose, so every dosing figure here traces back to older non-Western protocols or anecdotal use rather than a controlled trial or a prescribing guideline. We describe what circulates; we do not recommend it.[1][2]
Reviewed for accuracy · Last reviewed July 8, 2026There is no Western-validated human dose for epitalon. The figures discussed below come from older non-Western protocols and anecdotal use, not from controlled trials, so they are described rather than recommended:
The most commonly repeated pattern is a short daily subcutaneous course over roughly 10 – 20 days, sometimes repeated a few times per year, echoing the original Russian epithalamin and epitalon course protocols. Because none of this is anchored to controlled human dosing research, treat the numbers as a description of circulating practice, not a schedule to follow.
Given that the human safety profile is poorly characterized and the underlying longevity claims are preliminary, anyone considering epitalon should discuss it with a doctor rather than rely on vendor or forum figures.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Talk to a doctor before starting any compound.